Low merlin level is a biomarker for the sensitivity of ovarian carcinoma cells to focal adhesion kinase (FAK) inhibition

Nina R. Shah(Moores Cancer Center), David D. Schlaepfer(UC San Diego Health System), Denise C. Connolly(Fox Chase Cancer Center), Christine Jean(Centre National de la Recherche Scientifique), Kristy Ward(University of California San Diego), Sean Uryu(Pfizer (United States)), Florian J. Sulzmaier(National Foundation for Cancer Research), Xizhi Chen(Moores Cancer Center), Christine Lawson(University of California San Diego), Isabelle Tancioni(University of California San Diego)
Gynecologic Oncology
November 1, 2014
Cited by 0


Related Papers